Sep 16, 2026 05:27PM
Sep 16, 2026 05:27PM
Aug 24, 2026 04:05PM
Aug 24, 2026 04:05PM
Aug 19, 2026 04:05PM
Aug 19, 2026 04:05PM
Aug 12, 2026 04:05PM Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update
Aug 11, 2026 09:05AM
Aug 11, 2026 09:05AM
Aug 3, 2026 04:05PM
Jul 23, 2026 09:15AM
Jul 23, 2026 09:15AM
Jul 13, 2026 07:06AM
Jul 13, 2026 07:05AM Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer’s Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in P
Jul 6, 2026 04:05PM
Jul 6, 2026 04:05PM
Jun 18, 2026 09:20AM
Jun 18, 2026 09:20AM
Jun 9, 2026 09:20AM
Jun 9, 2026 09:20AM
Jun 4, 2026 09:15AM Longeveron to Present at BIO International Convention 2026
May 20, 2026 04:06PM
May 20, 2026 04:05PM
May 13, 2026 04:05PM
May 11, 2026 09:10AM
May 11, 2026 09:10AM
May 8, 2026 04:05PM
May 8, 2026 04:05PM Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Phase 2b Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)
May 5, 2026 04:15PM
Apr 8, 2026 09:15AM
Mar 17, 2026 04:05PM
Mar 12, 2026 09:00AM
Mar 11, 2026 04:05PM
Mar 11, 2026 04:05PM
Mar 10, 2026 09:01AM Longeveron secures $30 million private placement for clinical trials
Mar 10, 2026 09:00AM
Feb 25, 2026 11:05AM
Feb 25, 2026 11:05AM
Feb 13, 2026 04:30PM
Feb 13, 2026 04:30PM
Feb 5, 2026 09:15AM
Jan 29, 2026 09:15AM Longeveron receives Japan patent for stem cell potency testing methods
Jan 29, 2026 09:15AM
Jan 26, 2026 09:15AM
Jan 26, 2026 09:15AM
Dec 29, 2025 09:15AM
Dec 17, 2025 09:15AM
Dec 17, 2025 09:15AM
Dec 3, 2025 09:15AM Longeveron executives to speak at cardiovascular clinical trials forum
Dec 3, 2025 09:15AM

331,401 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All